Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Orthopediatrics (KIDS) Accumulated Depreciation & Amortization (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Accumulated Depreciation & Amortization for 10 consecutive years, with $21.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 10.69% to $21.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.1 million, a 10.69% increase, with the full-year FY2025 number at $21.1 million, up 10.69% from a year prior.
  • Accumulated Depreciation & Amortization was $21.1 million for Q4 2025 at Orthopediatrics, up from $19.1 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $21.1 million in Q4 2025 to a low of $10.7 million in Q4 2021.
  • A 5-year average of $16.3 million and a median of $17.4 million in 2023 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: soared 33.33% in 2021, then increased 9.75% in 2024.
  • Orthopediatrics' Accumulated Depreciation & Amortization stood at $10.7 million in 2021, then increased by 22.65% to $13.1 million in 2022, then soared by 32.72% to $17.4 million in 2023, then grew by 9.75% to $19.1 million in 2024, then grew by 10.69% to $21.1 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Accumulated Depreciation & Amortization are $21.1 million (Q4 2025), $19.1 million (Q4 2024), and $17.4 million (Q4 2023).